SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
trf12289-sup-0001-si.docx34K

Table S1. Study eligibility criteria

Table S2. Administration of 1500 mg of IV iron with currently available iron preparations and FCM

Table S3. Drug-related treatment-emergent adverse events experienced by >2 subjects during treatment phase (safety population)

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.